A Synthetic Multivalent Lipopeptide Derived from Pam3CSK4 with Irreversible Influenza Inhibition and Immuno‐Stimulating Effects
Small · 2024
DOI: 10.1002/smll.202307709 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Yong Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Materials, École Polytechnique Fédérale de Lausanne Station 12, Lausanne, CH-1015, Switzerland. Hauptthemen laut MEDLINE: Lipopeptides, Dendritic Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HORIZON EUROPE Marie Sklodowska-Curie Actions, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Werner Siemens-Stiftung.
Abstract (Originalsprache)
The activation of the host adaptive immune system is crucial for eliminating viruses. However, influenza infection often suppresses the innate immune response that precedes adaptive immunity, and the adaptive immune responses are typically delayed. Dendritic cells, serving as professional antigen‐presenting cells, have a vital role in initiating the adaptive immune response. In this study, an immuno‐stimulating antiviral system (ISAS) is introduced, which is composed of the immuno‐stimulating adjuvant lipopeptide Pam3CSK4 that acts as a scaffold onto which it is covalently bound 3 to 4 influenza‐inhibiting peptides. The multivalent display of peptides on the scaffold leads to a potent inhibition against H1N1 (EC 50 = 20 n M ). Importantly, the resulting lipopeptide, Pam3FDA, shows an irreversible inhibition mechanism. The chemical modification of peptides on the scaffold maintains Pam3CSK4's ability to stimulate dendritic cell maturation, thereby rendering Pam3FDA a unique antiviral. This is attributed to its immune activation capability, which also acts in synergy to expedite viral elimination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Materials, École Polytechnique Fédérale de Lausanne Station 12, Lausanne, CH-1015, Switzerland.
- Department of Microbiology and Molecular Medicine, University of Geneva, CMU Rue Michel-Servet 1, Geneva 4, CH-1211, Switzerland.
- Interschool Institute of Bioengineering, École Polytechnique Fédérale de Lausanne Station 12, Lausanne, CH-1015, Switzerland.
ORCID-Profile: Yong Zhu, Francesco Stellacci
Förderung
- HORIZON EUROPE Marie Sklodowska-Curie Actions
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Werner Siemens-Stiftung
Zitieren
APA
Zhu, Y., Wei, L., Zwygart, A. C., Gaínza, P., Khac, Q. O., Olgiati, F., Kurum, A., Tang, L., Correia, B., Tapparel, C., & Stellacci, F. (2024). A Synthetic Multivalent Lipopeptide Derived from Pam3CSK4 with Irreversible Influenza Inhibition and Immuno‐Stimulating Effects. Small. https://doi.org/10.1002/smll.202307709
Vancouver
Zhu Y, Wei L, Zwygart AC, Gaínza P, Khac QO, Olgiati F, et al. A Synthetic Multivalent Lipopeptide Derived from Pam3CSK4 with Irreversible Influenza Inhibition and Immuno‐Stimulating Effects. Small. 2024. doi:10.1002/smll.202307709
BibTeX
@article{Zhu2024,
author = {Zhu, Yong and Wei, Lixia and Zwygart, Arnaud Charles-Antoine and Gaínza, Pablo and Khac, Quy Ong and Olgiati, Francesca and Kurum, Armand and Tang, Li and Correia, Bruno and Tapparel, Caroline and Stellacci, Francesco},
title = {A Synthetic Multivalent Lipopeptide Derived from Pam3CSK4 with Irreversible Influenza Inhibition and Immuno‐Stimulating Effects},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202307709}
}
EUVIMED